BSC Medical - Gateway to your medical needsNew and Used Medical Equipment

Latest News

Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA(TM) by the U.S. FDA
Thu, 20 Jul 2017 15:52:34 GMT

The NDA contains data to support approval for YONSA, (abiraterone acetate) ultramicrosize tablets, for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Churchill Pharmaceuticals also announces positive results from the pivotal ST...
Biopharmaceuticals, Oncology, FDA
Churchill Pharmaceuticals, YONSA, abiraterone, Prostate Cancer

New Data Show TomoTherapy(R) System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
Thu, 20 Jul 2017 15:49:31 GMT

Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific Survival Rate and Post-Treatment Salivary Function SUNN...
Devices, Oncology
Accuray, TomoTherapy, radiosurgery, radiotherapy, RapidArc

Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Thu, 20 Jul 2017 15:43:02 GMT

These Data, Combined with Positive Results from Two Phase 3 Efficacy Studies, Support NDA Filing Planned for Fourth Quarter of 2017 DUBLIN, HERTFORDSHIRE, England and PITTSBURGH, July 19, 2017 -- (Healthcare Sales & Marketing Network) -- Theravance Bio...
Theravance Biopharma, Mylan, Revefenacin, COPD

NCCN Guidelines and NCCN Templates to be Integrated into ION Solutions' IntelliDoseTxM Treatment Management Module
Wed, 19 Jul 2017 14:54:41 GMT

Integration of NCCN clinical recommendations into ION Solutions' IntelliDoseTxM system will provide oncologists access to evidence-based treatment decision support based on the NCCN Guidelines® FORT WASHINGTON, Pa., July 19, 2017 -- (Healthcare Sale...
Devices, Oncology
National Comprehensive Cancer Network, NCCN, ION Solutions, AmerisourceBergen

Dr. Moncef Slaoui, former GlaxoSmithKline Chairman of Vaccines, Appointed to SutroVax Board of Directors
Wed, 19 Jul 2017 14:50:06 GMT

FOSTER CITY, Calif., July 19, 2017 -- (Healthcare Sales & Marketing Network) -- SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious dise...
Biopharmaceuticals, Personnel
SutroVax, Xpress CF

AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
Wed, 19 Jul 2017 14:47:54 GMT

REDWOOD CITY, Calif., July 19, 2017 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of ...
Biopharmaceuticals, Personnel
AcelRx Pharmaceuticals, Zalviso, sufentanil, sublingual

Quest Diagnostics Launches QHerit(TM), a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines
Wed, 19 Jul 2017 14:46:03 GMT

QHerit Expanded Carrier Screen helps both women and men across multiple ethnicities identify risk of passing 22 genetic diseases to their children MADISON, N.J., July 19, 2017 -- (Healthcare Sales & Marketing Network) -- Quest Diagnostics (NYSE: DGX), ...
Diagnostics, Product Launch
Quest Diagnostics, QHerit, Genetic Screening

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Wed, 19 Jul 2017 14:43:31 GMT

BD FACSLyric� Flow Cytometer System with BD Multitest� Assays Offers Reliability and Consistency FRANKLIN LAKES, N.J., July 19, 2017 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical t...
Devices, Diagnostics, FDA
BD , FACSLyric, flow cytometer

Fagron, Inc. Announces Launch Of LETS GEL KIT(TM) for Rapid Topical Anesthesia
Tue, 18 Jul 2017 15:52:05 GMT

New Unit-Dose Gel Alternative to TAC Available for Suture Preparations ST. PAUL, Minn., July 18, 2017 -- (Healthcare Sales & Marketing Network) -- Fagron, Inc. introduces LETS GEL KIT�, a line extension to their industry-leading topical anesthesia co...
Biopharmaceuticals, Product Launch
Fagron, LETS GEL KIT, Topical Anesthesia, SuturaGel

Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients with Duchenne Muscular Dystrophy
Tue, 18 Jul 2017 15:45:49 GMT

Designation Covers Broad Treatment of Duchenne Muscular Dystrophy (DMD) LOS ANGELES, July 18, 2017 -- (Healthcare Sales & Marketing Network) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies for Duch...
Biopharmaceuticals, FDA
Capricor Therapeutics, Duchenne muscular dystrophy

Source: HSMN NewsFeed